Capital Markets Law360 provides breaking news and analysis on the capital markets sector. Coverage includes stock and bond offerings, mortgage-backed securities, foreign exchange, follow-on offerings, and debt deals, as well as related litigation and policy developments.

Sign up for a 7-day FREE trial today!

Latest News in Capital Markets

• September 25, 2026

  DC Circ. Backs Bitcoin Fog Crypto Mixer Conviction

  The D.C. Circuit upheld the conviction of Bitcoin Fog operator Roman Sterlingov in a Friday opinion that found the government adequately tied his conduct to the D.C. venue and introduced sufficiently reliable forensic evidence to link him to the cryptocurrency mixing service.

• September 25, 2026

  Tariffs, Not Fraud, Hurt Apparel Co.'s Finances, Court Told

  Protective apparel company Lakeland Industries Inc. asked a New York federal court to dismiss a proposed investor class action accusing it of ignoring a former finance employee's concerns about its global sales data and concealing information about its true financial condition, saying missing earnings estimates is "unfortunate" but not fraud.

• September 25, 2026

  CFTC, Ex-HSBC Exec Set For Trial In Swap Manipulation Suit

  A New York federal judge has denied dual motions for summary judgment from the U.S. Commodity Futures Trading Commission and a former HSBC executive accused of manipulating the price of an interest rate swap ahead of a client's $2 billion bond offering, finding there are several material factual disputes about the executive's alleged conduct.

• September 25, 2026

  Cooley, Latham Steer RNA Drugmaker's Upsized $446M IPO

  San Diego-based biotechnology company ADARx Pharmaceuticals began trading publicly on Friday after raising $446 million in its initial public offering steered by Cooley LLP and Latham & Watkins LLP, adding to the growing list of biotech IPOs recently.

• September 25, 2026

  Negotiating The Scope Of The Stablecoin Customer ID Rule

  Though comments on bank regulators’ proposed rule for stablecoin issuers under the Genius Act generally agree that oversight would help prevent illicit activity, agencies must reconcile disagreement over whether to extend customer identification requirements from issuers' primary-market relationships to secondary-markets activity, say attorneys at Ballard Spahr.

See more Capital Markets news